Connect with us

Featured

BiR: Impact report – July 2016 & More

Tariq Abdullah

Published

on

As we improve the quality of articles and as we are nearing our first collective birthday, Bioinformatics Review has expanded its reach, opening new avenues. The progress is summarised as below:

  • We have partnered with London Business Conference Group to be an official media partner for Discovery Informatics and Analytics Summit 2016
  • Our scientific articles are starting to appear in Google Scholar, articles indexed there can be viewed by following this link.
  • Bioinformatics Review was visited over 143,801 times in July 2016.

As for DIAS Summit 2016, we are giving away 15% coupons to our readers. To claim a discount coupon, please visit our Facebook page.

Do share this page with your colleagues and refer them for a coupon.

Tariq is founder of Bioinformatics Review and CEO at IQL Technologies. His areas of expertise include algorithm design, phylogenetics, MicroArray, Plant Systematics, and genome data analysis. If you have questions, reach out to him via his homepage.

Advertisement
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Docking

Tutorial: Vina Output Analysis Using PyMol

Tariq Abdullah

Published

on

The analysis of Autodock Vina [1] results is a bit tricky in the sense of viewing all interactions and selecting the best pose. In our last video tutorial, we explained how to analyze docking results obtained from Vina using PyMol. This article is the written guide for the same. (more…)

Continue Reading

Docking

Video Tutorial: Autodock Vina Result Analysis with PyMol

Dr. Muniba Faiza

Published

on

This is a video tutorial to demonstrate the analysis of Autodock Vina results using PyMol, in continuation of our existing docking tutorial.

Continue Reading

Featured

Genome editing of human embryos using CRISPR/Cas9- crossing the ethics of gene editing?

Bioinformatics Review

Published

on

CRISPR/Cas9 system is a recently developed multi-purpose technology for genome editing [1,2] and its tool CRISPR-ERA/Cas9 is widely used as explained in the previous article [3]. The possible applications of this system have been discussed by its developers [4] and have been successfully applied for genome editing, gene function identification, and for gene therapy in animals and human cells [5-9]. Recently, a group of Chinese researchers has reported the editing of a genome using the CRISPR/Cas9 system in human embryo for the first time in history [5]. The team has attempted to remove ‘harmful’ genetic codes to be potentially replaced by the ‘good’ ones. The results are published in Protein & Cell journal [10] but have opened a topic for debate over crossing the ethics of gene editing. (more…)

Continue Reading

LATEST ISSUE

ADVERT